An early warning surveillance programme for detecting upper limb deterioration after treatment for breast cancer: A novel technology supported system

Upper limb morbidity is a well-recognised consequence of treatment for breast cancer that can develop for up to 6 years after treatment. However, the capacity to fully integrate evidence-based rehabilitation pathways into routine care for all patients is questionable due to limited resources.